ORPH (ORPH:NASDAQ) soared at $4.91, representing a gain of 23.4%. On Tue, Oct 12, 2021, ORPH:NASDAQ hit a New 2-Week Intraday High of $4.31. The stock got featured on our News Catalysts scanner on Tue, Oct 05, 2021 at 12:31 PM in the 'BIOTECH' category. From Tue, Sep 28, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Aug 11, 2021 at $7.14 with a volume of 8B+, and its share price has been moving sideways in recent weeks.
About ORPH (ORPH:NASDAQ)
Orphazyme A/S is a Danish biotech company. It is engaged in the development of paradigm-changing medicines for the treatment of protein misfolding diseases.
Top 10 Gainers:
- JSPR (JSPR:NASDAQ), 105.13%
- Waitr Holdings Inc. (WTRH:NASDAQ), 58.45%
- CRXT (CRXT:NASDAQ), 29.02%
- Sesen Bio, Inc. (SESN:NASDAQ), 26.9%
- ORPH (ORPH:NASDAQ), 23.37%
- Puxin Limited (NEW:NYSE), 23.02%
- RDW (RDW:NYSE), 22.03%
- Cabot Oil & Gas Corporation (COG:NYSE), 20.08%
- HUDI (HUDI:NASDAQ), 19.56%
- Independence Contract Drilling, Inc. (ICD:NYSE), 18.94%